Lv6
2980 积分 2021-02-23 加入
Mortality and Heart Failure Hospitalization in Patients With HFpEF on Mineralocorticoid Receptor Antagonists: A Systematic Review and Meta-Analysis
2天前
已完结
Finerenone and Empagliflozin in Type 2 Diabetes
2天前
求助中
Pre‐Pregnancy GLP‐1 Receptor Agonist or Tirzepatide Use and Gestational Diabetes Risk: Evaluating Pharmacodynamic Carry‐Over Versus Post‐Discontinuation Metabolic Rebound in a Multinational Federated Cohort
19天前
已完结
Comparative effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists on the risk of incident dementia after acute kidney injury: a target-trial emulation
19天前
已完结
Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
19天前
已完结
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)
20天前
已关闭
Statin therapy increased risk for 4 of 66 adverse outcomes listed in product labels compared with placebo at a median 4.5 y
23天前
已完结
In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than oral semaglutide at 52 wk
23天前
已完结
In overweight or obesity, intermittent fasting does not differ from dietary advice but increases weight loss vs. no intervention
23天前
已完结
Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes
23天前
已完结
皖公网安备34019202002308
